Godrej Properties Consolidated Financials for Q1 FY27 Results


•           Godrej Properties’ bookings grew 22% YoY to INR 8,651 crores.

•           This is the highest first quarter booking value achieved by Godrej Properties.

•           Collections grew by 18% YoY to INR 4,348 crores.

•           Added INR 9,500 crore of future sales potential through portfolio additions in Q1 FY27.

•           Net profit of INR 350 crore for Q1 FY27

Godrej Properties Limited (GPL), a leading national real estate developer, announced its financial results for the first quarter ended June 30, 2026.

CORPORATE HIGHLIGHTS:

•           Sales highlights

o          Booking value in Q1 FY27 grew to INR 8,651 crores, a YoY growth of 22%. This was achieved through the sale of 3,738 units with a total area of 6.2 million sq. ft.

o          This is the 6th consecutive quarter in which GPL’s booking value has exceeded INR 7,000 crore.

o          This is the highest first quarter booking value achieved by Godrej Properties.

o          Booking value in the quarter was driven by strong demand in several new project launches including Godrej Vanantara (INR 3,237 crores) in Bengaluru, Godrej Samaris (INR 1,248 crores) in Gurugram and Godrej Brooklyn Avenue (INR 317 crores) in Hyderabad.

o          Bookings contribution were led by Bengaluru (44%), followed by MMR (21%), NCR (18%), Pune (11%) & Hyderabad (5%).

•           Collections and cashflow highlights

o          Q1 FY27 collections stood at INR 4,348 crore representing a YoY growth of 18%.

o          Q1 FY27 OCF stood at INR 399 crore

o          Construction and related outflow increased by 54% YoY in Q1 FY27.

•           Business development highlights

o          GPL has added 3 new projects with an estimated saleable area of approximately

8.0 million sq. ft. and expected booking value of INR 9,500 crore in Q1 FY27

o          GPL has achieved 48% of its annual guidance for business development for FY27 in the first quarter.

•           Other highlights

o          GPL has delivered 0.9 million sq. ft. of projects in Q1 FY27

o          Godrej Properties was included in TIME World’s Most Sustainable Companies 2026 the only real estate company in India to feature on the list.

o          Godrej Properties received Golden Peacock National Quality Award 2026

Commenting on the performance of Q1 FY27, Mr. Pirojsha Godrej, Executive Chairperson, Godrej Properties Limited, said:

“Godrej Properties delivered another solid quarter for bookings, collections, business development and earnings. We expect the sales momentum to continue for rest of the year led by strong end user demand across key markets. We remain on track to deliver on bookings of over INR 39,000 crore and collections of INR 24,000 crores for the year, which will allow us to generate approximately Rs. 9,000 crores of operating cash flow, which in turn will allow us to continue to invest in sustainable growth. We will continue to seek to gain market share through outstanding design, timely delivery, and high-quality developments.”

Financial Overview (Consolidated)

Q1 FY27 performance overview compared with Q1 FY26

•           Total Income declined by 16% to INR 1,337 crore as compared to INR 1,593 crore

•           EBITDA declined by 40% to INR 545 crore as compared to INR 915 crore

•           Net Profit declined by 42% to INR 350 crore as compared to INR 600 crore

•           EPS# amounted to INR 11.62 as compared to INR 19.92

 

.

Comments

Post a Comment

Popular posts from this blog

BPCL Dealer network launches “Fuelling the Festive Spirit” Campaign

Image
  Bharat Petroleum Corporation Limited (BPCL) dealer network has rolled out its festive season campaign, “Fuelling the Festive Spirit”, from 22nd September to 31st October 2025 across 3,000 Retail Outlets in Andhra Pradesh, Telangana, Karnataka, and Tamil Nadu.   Customers fuelling up with eligible transactions can win exciting prizes of 17 car and  83 Bikes through QR-based digital  slogan context participation. BPCL spokesperson said, “Festivals in India are a time of joy, giving, and togetherness. With ‘Fuelling the Festive Spirit,’ we are delighted to reward our customers and empower our frontline teams, making every visit to our retail outlets during this festive season truly memorable.”
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more

Gleneagles Hospital Successfully Treats Rare CNS (Brain) Lymphoma with Advanced CAR-T Cell Therapy

Image
Gleneagles Hospital Chennai, a part of Fortis Healthcare, has successfully treated a 49-year-old patient from Andhra Pradesh diagnosed with a rare and aggressive form of CNS(brain) lymphoma using advanced CAR-T cell therapy. Despite developing multiple serious treatment-related complications, the patient achieved complete remission and is doing well. The patient presented with complaints of persistent headache, giddiness, difficulty in walking, and weakness in his left arm and leg. Detailed investigations confirmed Primary Central Nervous System Lymphoma (PCNSL) , a rare type of lymphoma that affects the brain and is known to be difficult to treat. The patient initially received high-dose chemotherapy, the standard first-line treatment for this condition. However, the disease continued to progress despite four cycles of treatment. He subsequently underwent radiotherapy with chemotherapy, followed by oral targeted therapy as bridging treatment. As the lymphoma remained resistant to ...
Read more